{
    "organizations": [],
    "uuid": "4ce110545f1f934ffa5f2338ba5380a4ff1a5af3",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-eyenovia-reports-q4-loss-per-share/brief-eyenovia-reports-q4-loss-per-share-0-84-idUSASC09UE5",
    "ord_in_thread": 0,
    "title": "BRIEF-Eyenovia Reports Q4 Loss Per Share $0.84",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "April 2 (Reuters) - Eyenovia Inc:\n* EYENOVIA ANNOUNCES FOURTH QUARTER AND FULL YEAR 2017 FINANCIAL RESULTS\n* Q4 LOSS PER SHARE $0.84 * ‍AS OF DECEMBER 31, 2017, COMPANY’S CASH WAS APPROXIMATELY $5.2 MILLION​\n* ‍ EXPECTS TO ANNOUNCE FULL AND DETAILED RESULTS FOR EYN PG21 CLINICAL STUDY IN Q2 OF 2018​ Source text for Eikon: Further company coverage:\n ",
    "published": "2018-04-02T20:59:00.000+03:00",
    "crawled": "2018-04-03T16:03:47.017+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "april",
        "reuters",
        "eyenovia",
        "inc",
        "eyenovia",
        "announces",
        "fourth",
        "quarter",
        "full",
        "year",
        "financial",
        "result",
        "q4",
        "loss",
        "per",
        "share",
        "december",
        "company",
        "cash",
        "approximately",
        "expects",
        "announce",
        "full",
        "detailed",
        "result",
        "eyn",
        "pg21",
        "clinical",
        "study",
        "q2",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}